Team ID: 14674
Team Captain: Charlene Rivera
9 Members: 9 riders
Members: Mike Aschieris, Charles Claydon, Jean Compton, Desirae Day, Michael Hyat, Elaine Pittman, Charlene Rivera, Christine Spears, Robert Spears
We've raised: $6,289
Lifetime Raise: $74277.8300
Why We Participate:
We formed Team Chamorro Roll in 2015 to celebrate the life of Chris Rivera, husband, father and friend. In 2014 Chris was diagnosed with terminal lung cancer. He lived, he loved and he fought to the end. The name Chamorro represents the people of Guam, where this team's inspiration originated from.
We all have a family member, friend, co-worker, or perhaps yourself, that has been affected by cancer. Please join us in the fight against cancer by participating in the Padres Pedal the Cause San Diego cycling fundraiser on November 17, 2018.
This is our fourth year riding for PADRES PEDAL and because of your generous donations TEAM CHAMORRO ROLL has raised OVER $70,000!
Please help us in this journey by making a donation today, and give with confidence knowing that 100% of proceeds go directly to accelerating cancer research. Padres Pedal the Cause has the mission of providing funding for cancer research at UC San Diego Moores Cancer Center, Sanford-Burnham Medical Research Institute, Salk Institute for Biological Studies, and Rady Children's Hospital-San Diego through their annual cycling fundraiser in hopes that the collaborative research funded by this event will ultimately lead to a cure for cancer.
Important Padres Pedal Dates:
Saturday, Sept 1, 2018
Deadline to Commit to Incentive Levels to receive custom apparel by Nov. 17
Saturday, Nov 17, 2018
Saturday, Dec 1, 2018
Click to see the entire Calendar of Events.
100% of the donations raised by Padres Pedal the Cause stay in San Diego to fund life-saving cancer research projects. Learn more by clicking below.
How to get involved
Not yet registered? Click below to learn more on how to become involved. Ride, run, walk, spin or volunteer - everyone can participate and join the fight against cancer.